Reg reform bill's risk assessment exemption provisions called inadequate by FDA.
This article was originally published in The Tan Sheet
Executive Summary
FDA DEEMS S 343's RISK ASSESSMENT EXEMPTION FOR HEALTH THREATS INADEQUATE to "permit the agency to take expeditious action to avert harm." In an analysis of a revised version of the "Comprehensive Regulatory Reform Act" supported by Senate Majority Leader Robert Dole (R-Kan.) and Sen. Bennett Johnston (D-La.), FDA asserted that the exemption from conducting risk assessments for "likely health and safety threats" would not allow timely FDA actions.